Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tadao Ishida

Showing results (41-50 of 151) with videos related to

Pageof 16
Sort By:
Internal Medicine (Tokyo, Japan)|July 13, 2022
Development of Polyneuropathy, Organomegaly, Endocrinopathy, M Protein, and Skin Changes Syndrome after Conversion from Plasmacytoma of Bone to Multiple MyelomaKeiko Hatano, Kenta Orimo, Mizuki Ogura, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 6, 2018
[Carfilzomib, lenalidomide, and dexamethasone therapy for refractory and relapsed multiple myeloma: a single-center study of 29 patients]Kiyoshi Okazuka, Tadao Ishida, Kota Sato, et al.
Apoptosis : an International Journal on Programmed Cell Death|October 20, 2006
Parthenolide-induced apoptosis in multiple myeloma cells involves reactive oxygen species generation and cell sensitivity depends on catalase activityWei Wang, Masaaki Adachi, Rina Kawamura, et al.
Internal Medicine (Tokyo, Japan)|October 13, 2017
Elevation of Plasmin-α2-plasmin Inhibitor Complex Predicts the Diagnosis of Systemic AL Amyloidosis in Patients with Monoclonal ProteinKazuya Ishiguro, Toshiaki Hayashi, Yoshihiro Yokoyama, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 1, 2006
[Effective combination therapy of bortezomib and dexamethasone for two patients with refractory multiple myeloma]Hiroshi Ikeda, Toshiaki Hayashi, Masahiro Nojima, et al.
International Journal of Hematology|October 5, 2014
Autologous stem cell transplantation for AL amyloidosis: adjustment of melphalan dose by factors including BNPToshiaki Hayashi, Hiroshi Ikeda, Tetsuyuki Igarashi, et al.
Rheumatology (Oxford, England)|May 19, 2009
The analysis of interleukin-6 in patients with systemic IgG4-related plasmacytic syndrome--expansion of SIPS to the territory of Castleman's diseaseMotohisa Yamamoto, Hiroki Takahashi, Kohhei Hasebe, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2018
The Role of Allogeneic Transplantation for Multiple Myeloma in the Era of Novel Agents: A Study from the Japanese Society of MyelomaKoji Kawamura, Nobuhiro Tsukada, Yoshinobu Kanda, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2002
The antisense approach in amyloid light chain amyloidosis: identification of monoclonal Ig and inhibition of its production by antisense oligonucleotides in in vitro and in vivo modelsSatoko Ohno, Mitsuru Yoshimoto, Saho Honda, et al.
Cancer Science|July 20, 2012
Model of translational cancer research in multiple myelomaHiroshi Yasui, Tadao Ishida, Reo Maruyama, et al.
Pageof 16

Showing results (41-50 of 151) with videos related to

Sort By:
Pageof 16
Internal Medicine (Tokyo, Japan)|July 13, 2022
Development of Polyneuropathy, Organomegaly, Endocrinopathy, M Protein, and Skin Changes Syndrome after Conversion from Plasmacytoma of Bone to Multiple MyelomaKeiko Hatano, Kenta Orimo, Mizuki Ogura, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 6, 2018
[Carfilzomib, lenalidomide, and dexamethasone therapy for refractory and relapsed multiple myeloma: a single-center study of 29 patients]Kiyoshi Okazuka, Tadao Ishida, Kota Sato, et al.
Apoptosis : an International Journal on Programmed Cell Death|October 20, 2006
Parthenolide-induced apoptosis in multiple myeloma cells involves reactive oxygen species generation and cell sensitivity depends on catalase activityWei Wang, Masaaki Adachi, Rina Kawamura, et al.
Internal Medicine (Tokyo, Japan)|October 13, 2017
Elevation of Plasmin-α2-plasmin Inhibitor Complex Predicts the Diagnosis of Systemic AL Amyloidosis in Patients with Monoclonal ProteinKazuya Ishiguro, Toshiaki Hayashi, Yoshihiro Yokoyama, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 1, 2006
[Effective combination therapy of bortezomib and dexamethasone for two patients with refractory multiple myeloma]Hiroshi Ikeda, Toshiaki Hayashi, Masahiro Nojima, et al.
International Journal of Hematology|October 5, 2014
Autologous stem cell transplantation for AL amyloidosis: adjustment of melphalan dose by factors including BNPToshiaki Hayashi, Hiroshi Ikeda, Tetsuyuki Igarashi, et al.
Rheumatology (Oxford, England)|May 19, 2009
The analysis of interleukin-6 in patients with systemic IgG4-related plasmacytic syndrome--expansion of SIPS to the territory of Castleman's diseaseMotohisa Yamamoto, Hiroki Takahashi, Kohhei Hasebe, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2018
The Role of Allogeneic Transplantation for Multiple Myeloma in the Era of Novel Agents: A Study from the Japanese Society of MyelomaKoji Kawamura, Nobuhiro Tsukada, Yoshinobu Kanda, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2002
The antisense approach in amyloid light chain amyloidosis: identification of monoclonal Ig and inhibition of its production by antisense oligonucleotides in in vitro and in vivo modelsSatoko Ohno, Mitsuru Yoshimoto, Saho Honda, et al.
Cancer Science|July 20, 2012
Model of translational cancer research in multiple myelomaHiroshi Yasui, Tadao Ishida, Reo Maruyama, et al.
Pageof 16